Publication: Rapid and sensitive lateral flow immunoassay for influenza antigen using fluorescently-doped silica nanoparticles
Submitted Date
Received Date
Accepted Date
Issued Date
2014-01-01
Copyright Date
Announcement No.
Application No.
Patent No.
Valid Date
Resource Type
Edition
Resource Version
Language
File Type
No. of Pages/File Size
ISBN
ISSN
14365073
00263672
00263672
eISSN
Scopus ID
WOS ID
Pubmed ID
arXiv ID
Call No.
Other identifier(s)
2-s2.0-84891553547
Journal Title
Volume
Issue
item.page.oaire.edition
Start Page
End Page
Access Rights
Access Status
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Physical Location
Bibliographic Citation
Microchimica Acta. Vol.181, No.1-2 (2014), 223-230
Citation
Suwussa Bamrungsap, Chayachon Apiwat, Warangkana Chantima, Tararaj Dharakul, Natpapas Wiriyachaiporn (2014). Rapid and sensitive lateral flow immunoassay for influenza antigen using fluorescently-doped silica nanoparticles. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/33657.
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Rapid and sensitive lateral flow immunoassay for influenza antigen using fluorescently-doped silica nanoparticles
Alternative Title(s)
Author's Affiliation
Author's E-mail
Editor(s)
Editor's Affiliation
Corresponding Author(s)
Creator(s)
Compiler
Advisor(s)
Illustrator(s)
Applicant(s)
Inventor(s)
Issuer
Assignee
Other Contributor(s)
Series
Has Part
Abstract
We report on a lateral flow immunoassay (LFIA) for influenza A antigen using fluorescently-doped silica nanoparticles as reporters. The method is taking advantage of the high brightness and photostability of silica nanoparticles (doped with the dye Cy5) and the simplicity and rapidity of LFIA. The nucleoprotein of influenza A virion (one of its most abundant structural proteins) was used as a model to demonstrate a performance of the LFIA. Under optimized conditions and by using a portable strip reader, the fluorescence-based LFIA is capable of detecting a recombinant nucleoprotein as low as 250 ng · mL-1 using a sample volume of 100 μL, within 30 min, and without interference by other proteins. The successful detection of the nucleoprotein in infected allantoic fluid demonstrated the functionality of the method. By comparison with a commercial influenza A test based on gold nanoparticles as reporters, the system provides an 8-fold better sensitivity. [Figure not available: see fulltext.] © 2013 Springer-Verlag Wien.